Grupo GEIS Grupo GEIS

ACCESS YOUR ACCOUNT

User
Password
Remember me
  • Forgot your password?
  • Forgot User?
  • Español
  • English

Main Menu

  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guides
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
    • Healthcare Industry Today
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to records
    • Reports
  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guides
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
    • Healthcare Industry Today
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to records
    • Reports
que-son-sarcomas
  1. Home
  2. What are sarcomas?
  3. Treatments

Treatments

tratamientos imgAs there are many kinds of sarcomas, there are also diverse treatments to cure or improve them. The main ones are surgery, radiotherapy and chemotherapy.

New treatments against cancer, based on the knowledge of its most intimate molecular mechanisms, have not yet changed the ways of treating sarcomas on the same way than other more frequent cancers, like breast of lung tumors. However, this new age of cancer treatment is also arriving to the field of sarcomas. For example, GIST, once practically untreatable with conventional chemotherapy, has today a considerably better prognosis thanks to imatinib and other molecular based drugs.

Although sarcomas have a great deal of varieties, that diversity is nothing compared to the one present from patient to patient. There are children, adults and elderly; with a reasonable health or frankly weakened; there are those that are facing their first treatment and those who had been already submitted to previous lines of treatment. To conclude, you could almost say that there are not two cases alike, so a team focused on sarcoma treatments has to put forward all its knowledge and experience in the tough task of adapting the current treatments to the particular needs of each and every patient.

There are not two cases alike, so a team focused on sarcoma treatments has to put forward all its knowledge and experience in the tough task of adapting the current treatments to the particular needs of each and every patient.

Everything must start displaying on a realistic way which is the objective of the treatment on every case. Sometimes it is about curing a disease; on others, just to diminish the chances of future relapses after a surgery. Sometimes, what has to be done is to prolong the lifetime in a situation where healing is just not possible anymore, other times all that we want is to control the symptoms the quickest way possible. If that objective is not clear, it is impossible to conclude if the treatment has achieved or not our expectatives. Any patient that wishes to actively participate on his/her treatment should not face it without asking that “What for?” to his doctor in the clearest way possible. And the latter should not start any treatment without answering to his patient with all possible sincerity.

  • WHAT ARE SARCOMAS?
  • Soft Tissue Sarcomas
  • Skeletal sarcomas
  • Ewing sarcoma
  • Gastrointestinal Stromal Tumor (GIST)
  • Pediatric Sarcoma
  • Treatments
  • Surgery
  • Chemotherapy
  • Radiotherapy

Grupo GEIS

ABOUT GEIS

  • About us
  • What are sarcomas
  • Patients
  • Request GEIS scientific endorsement

INFORMATION

  • GEIS Symposiums
  • Schedule
  • News
  • Employment opportunities
 

This site contents are not a valid substitute for medical diagnosis, prognosis or treatment given by a doctor. GEIS must insist that the decisions related to sarcoma patients must always be sanctioned by a specialist familiar to this condition after personally meeting the subject. This website operates under its User Terms and Conditions.

Copyright © 2023 GEIS Group. All Rights Reserved. Diseño Comuniland.
  • Legal disclaimer
  • Privacy policy
  • Sitemap
  • Cookies
  • Contact us